Healthcare & Life Sciences
Antios Therapeutics
series-b
series-b
Stage
1
Investors
About
Antios Therapeutics is a biopharmaceutical company founded in 2018 that develops therapies aimed at treating and curing viral diseases.
Explore Antios Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.